Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
Oncology Reports · 2023
DOI: 10.3892/or.2023.8561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Ryosuke Takahashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Ferroptosis, Antineoplastic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cell Physiology, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan.
- Department of Obstetrics and Gynecology, Graduate School of Medicine, Kobe University, Kobe 650‑0017, Japan.
Zitieren
APA
Takahashi, R., Kamizaki, K., Yamanaka, K., Terai, Y., & Minami, Y. (2023). Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin. Oncology Reports. https://doi.org/10.3892/or.2023.8561
Vancouver
Takahashi R, Kamizaki K, Yamanaka K, Terai Y, Minami Y. Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin. Oncology Reports. 2023. doi:10.3892/or.2023.8561
BibTeX
@article{Takahashi2023,
author = {Takahashi, Ryosuke and Kamizaki, Koki and Yamanaka, Keitaro and Terai, Yoshito and Minami, Yasuhiro},
title = {Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin},
journal = {Oncology Reports},
year = {2023},
doi = {10.3892/or.2023.8561}
}
EUVIMED